Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,157 | -10,324 | -4,343 | -20,057 | -14,415 |
| Depreciation Amortization | 7 | 4 | 2 | 19 | 15 |
| Accounts receivable | -65 | 39 | 51 | -67 | -249 |
| Other Working Capital | -2,070 | -972 | -2,118 | 3,063 | 2,031 |
| Other Operating Activity | 3,064 | 1,223 | 226 | 857 | 728 |
| Operating Cash Flow | $-18,223 | $-10,030 | $-6,182 | $-16,185 | $-11,890 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -2 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-2 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 2,000 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 14,537 | 12,149 |
| Other Financing Activity | -96 | -95 | -69 | 9,354 | 0 |
| Financing Cash Flow | $9,904 | $1,906 | $-69 | $23,891 | $12,149 |
| Beginning Cash Position | 9,247 | 9,247 | 9,247 | 1,543 | 1,543 |
| End Cash Position | 928 | 1,122 | 2,995 | 9,247 | 1,802 |
| Net Cash Flow | $-8,319 | $-8,125 | $-6,251 | $7,703 | $258 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,223 | -10,030 | -6,182 | -16,185 | -11,890 |
| Capital Expenditure | N/A | N/A | N/A | -2 | N/A |
| Free Cash Flow | -18,223 | -10,030 | -6,182 | -16,187 | -11,890 |